학술논문

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Document Type
Article
Source
In: Nature Communications. (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723